Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Congenital Penile Rhabdomyosarcoma on FDG PET/CT.

Wu C, Zhuang H.

Clin Nucl Med. 2018 Nov;43(11):852-853. doi: 10.1097/RLU.0000000000002268.

PMID:
30179913
2.

Utility of ¹⁸F-FDG PET/CT in identifying penile squamous cell carcinoma metastatic lymph nodes.

Rosevear HM, Williams H, Collins M, Lightfoot AJ, Coleman T, Brown JA.

Urol Oncol. 2012 Sep;30(5):723-6. doi: 10.1016/j.urolonc.2010.09.015. Epub 2011 Mar 10.

PMID:
21396850
3.

18F-FDG PET/CT for staging of penile cancer.

Scher B, Seitz M, Reiser M, Hungerhuber E, Hahn K, Tiling R, Herzog P, Reiser M, Schneede P, Dresel S.

J Nucl Med. 2005 Sep;46(9):1460-5.

4.

DaPeCa-3: promising results of sentinel node biopsy combined with (18) F-fluorodeoxyglucose positron emission tomography/computed tomography in clinically lymph node-negative patients with penile cancer - a national study from Denmark.

Jakobsen JK, Alslev L, Ipsen P, Costa JC, Krarup KP, Sommer P, Nerstrøm H, Toft BG, Høyer S, Bouchelouche K, Jensen JB.

BJU Int. 2016 Jul;118(1):102-11. doi: 10.1111/bju.13243. Epub 2015 Aug 22.

5.

Primary penile lymphoma: the use of PET-CT for accurate staging and response monitoring.

Karunanithi S, Sharma P, Naswa N, Soundararajan R, Mohapatra T, Malhotra A, Bal C, Kumar R.

Diagn Interv Radiol. 2013 Mar-Apr;19(2):130-3. doi: 10.4261/1305-3825.DIR.6253-12.1.

6.

18F-FDG PET/CT findings in patients with Kikuchi disease.

Kong E, Chun K, Hong Y, Hah J, Cho I.

Nuklearmedizin. 2013;52(3):101-6. doi: 10.3413/Nukmed-0513-12-06. Epub 2013 Mar 27.

PMID:
23681151
7.

18F-FDG PET/CT as a prognostic factor in penile cancer.

Salazar A, Júnior EP, Salles PGO, Silva-Filho R, Reis EA, Mamede M.

Eur J Nucl Med Mol Imaging. 2018 Aug 24. doi: 10.1007/s00259-018-4128-7. [Epub ahead of print]

PMID:
30143840
8.

[18F]FDG PET/CT for assessing inguinal lymph nodes in patients with penile cancer - correlation with histopathology after inguinal lymphadenectomy.

Dräger DL, Heuschkel M, Protzel C, Erbersdobler A, Krause BJ, Hakenberg OW, Schwarzenböck SM.

Nuklearmedizin. 2018 Feb;57(1):26-30. doi: 10.3412/Nukmed-0932-17-10. Epub 2018 Feb 21.

PMID:
29536497
9.

[Dramatic response of penile cancer with inguinal lymph node metastases to neoadjuvant chemotherapy with paclitaxel, ifosfamide and cisplatin : a case report].

Kubota Y, Nakano M, Nagai S, Matsuoka K, Arakawa H, Horie K, Deguchi T, Kato H.

Hinyokika Kiyo. 2015 Jan;61(1):33-7. Japanese.

10.

Accuracy of 18F-FDG PET/CT for diagnosing inguinal lymph node involvement in penile squamous cell carcinoma: systematic review and meta-analysis of the literature.

Sadeghi R, Gholami H, Zakavi SR, Kakhki VR, Horenblas S.

Clin Nucl Med. 2012 May;37(5):436-41. doi: 10.1097/RLU.0b013e318238f6ea. Review.

PMID:
22475891
11.

Scanning with 18F-FDG-PET/CT for detection of pelvic nodal involvement in inguinal node-positive penile carcinoma.

Graafland NM, Leijte JA, Valdés Olmos RA, Hoefnagel CA, Teertstra HJ, Horenblas S.

Eur Urol. 2009 Aug;56(2):339-45. doi: 10.1016/j.eururo.2009.05.016. Epub 2009 May 19.

PMID:
19477581
12.

Detection of inguinal lymph node involvement in penile squamous cell carcinoma by 18F-fluorodeoxyglucose PET/CT: a prospective single-center study.

Schlenker B, Scher B, Tiling R, Siegert S, Hungerhuber E, Gratzke C, Tilki D, Reich O, Schneede P, Bartenstein P, Stief CG, Seitz M.

Urol Oncol. 2012 Jan-Feb;30(1):55-9. doi: 10.1016/j.urolonc.2009.10.012. Epub 2009 Dec 21.

PMID:
20022269
13.

The role of PET/CT imaging in penile cancer.

Ottenhof SR, Vegt E.

Transl Androl Urol. 2017 Oct;6(5):833-838. doi: 10.21037/tau.2017.04.36. Review.

14.

Penile metastasis from rectal cancer by PET/CT.

Alzayed MF, Artho G, Nahal A, Hickeson M.

Clin Nucl Med. 2015 Apr;40(4):e245-50. doi: 10.1097/RLU.0000000000000635.

PMID:
25546188
15.

The contribution of ¹⁸F-FDG PET/CT in a patient with cutaneous metastases of squamous cell carcinoma of the penis.

Banzo J, Ubieto MA, Andrés A, Tardín L, Rambalde EF, Cancer LF, Razola P, Prats E.

Rev Esp Med Nucl Imagen Mol. 2014 Sep-Oct;33(5):293-5. doi: 10.1016/j.remn.2014.04.002. Epub 2014 May 25.

16.

Incidentally Detected Small Intestine Intussusception Caused by Primary Small Intestine Carcinoma on 18F-FDG PET/CT.

Lee H, Oh SW, Kim YK.

Nucl Med Mol Imaging. 2017 Sep;51(3):266-270. doi: 10.1007/s13139-016-0464-3. Epub 2017 Jan 10.

17.

Positive lymphoscintigraphy (ILS) and negative computed tomography for metastatic penile cancer.

Bantis A, Sountoulides P, Kalaitzis C, Boussios N, Giannakopoulos S, Zissimopoulos A.

Hell J Nucl Med. 2011 Sep-Dec;14(3):309-10.

PMID:
22087456
18.

Additional Benefit of F-18 FDG PET/CT in the staging and follow-up of pediatric rhabdomyosarcoma.

Ricard F, Cimarelli S, Deshayes E, Mognetti T, Thiesse P, Giammarile F.

Clin Nucl Med. 2011 Aug;36(8):672-7. doi: 10.1097/RLU.0b013e318217ae2e.

PMID:
21716019
19.

(18)F-FDG PET-CT for Staging of Conjunctival Melanoma.

Damian A, Gaudiano J, Engler H, Alonso O.

World J Nucl Med. 2013 Jan;12(1):45-7. doi: 10.4103/1450-1147.113965.

20.

[CCAFU Recommendations 2013: Penile cancer].

Rigaud J, Avancès C, Camparo P, Durand X, Fléchon A, Murez T, Sèbe P, Coloby P, Culine S, Iborra F, Mottet N, Soulié M; Les membres du CCAFU.

Prog Urol. 2013 Nov;23 Suppl 2:S135-44. doi: 10.1016/S1166-7087(13)70051-4. French.

PMID:
24485288

Supplemental Content

Support Center